CXCR2 and breast cancer: Our results identify CXCR2 activation as a major regulator of not only the recruitment of Tumor-Associated Neutrophils toward brain metastatic variants of breast cancers, but also their propensity of NETosis with unique tumor-aiding spatio-temporal dynamics.